BIO X CELL Antibodies & Hybridomas — page 19 of 22
Antibodies & Hybridomas
Page 19 of 22
| Specificity | Clone | Host Species | Reactive Species | Format | Size | |
|---|---|---|---|---|---|---|
| PD-L1 | 10F.9G2™ | Rat | mouse | unconjugated | 50 mg | More Info |
| PD-L1 | 10F.9G2™ | Rat | mouse | unconjugated | 5 mg | More Info |
| PD-L1 | 29E.2A3 | Mouse | human | unconjugated | 100 mg | More Info |
| PD-L1 | 29E.2A3 | Mouse | human | unconjugated | 1 mg | More Info |
| PD-L1 | 29E.2A3 | Mouse | human | unconjugated | 25 mg | More Info |
| PD-L1 | 29E.2A3 | Mouse | human | unconjugated | 50 mg | More Info |
| PD-L1 | 29E.2A3 | Mouse | human | unconjugated | 5 mg | More Info |
| PD-L1 | 10F.2H11 | Rat | mouse | unconjugated | 100 mg | More Info |
| PD-L1 | 10F.2H11 | Rat | mouse | unconjugated | 1 mg | More Info |
| PD-L1 | 10F.2H11 | Rat | mouse | unconjugated | 25 mg | More Info |
| PD-L1 | 10F.2H11 | Rat | mouse | unconjugated | 50 mg | More Info |
| PD-L1 | 10F.2H11 | Rat | mouse | unconjugated | 5 mg | More Info |
| PD-L1 | 10F.9G2™ | Rat | mouse | unconjugated | 100 mg | More Info |
| PD-L1 | 10F.9G2™ | Rat | mouse | unconjugated | 25 mg | More Info |
| PD-L1 | 10F.9G2™ | Rat | mouse | unconjugated | 50 mg | More Info |
| PD-L1 | 10F.9G2™ | Rat | mouse | unconjugated | 5 mg | More Info |
| PD-L1 | 368A.4H1 | Mouse | human, mouse, rat | unconjugated | 100 mg | More Info |
| PD-L1 | 368A.4H1 | Mouse | human, mouse, rat | unconjugated | 1 mg | More Info |
| PD-L1 | 368A.4H1 | Mouse | human, mouse, rat | unconjugated | 25 mg | More Info |
| PD-L1 | 368A.4H1 | Mouse | human, mouse, rat | unconjugated | 50 mg | More Info |
| PD-L1 | 368A.4H1 | Mouse | human, mouse, rat | unconjugated | 5 mg | More Info |
| PD-L1 | JC071 | Mouse | canine | unconjugated | 100 mg | More Info |
| PD-L1 | JC071 | Mouse | canine | unconjugated | 1 mg | More Info |
| PD-L1 | JC071 | Mouse | canine | unconjugated | 25 mg | More Info |
| PD-L1 | JC071 | Mouse | canine | unconjugated | 50 mg | More Info |
| PD-L1 | JC071 | Mouse | canine | unconjugated | 5 mg | More Info |
| PD-L2 | TY25 | Rat | mouse | unconjugated | 100 mg | More Info |
| PD-L2 | TY25 | Rat | mouse | unconjugated | 1 mg | More Info |
| PD-L2 | TY25 | Rat | mouse | unconjugated | 25 mg | More Info |
| PD-L2 | TY25 | Rat | mouse | unconjugated | 50 mg | More Info |
| PD-L2 | TY25 | Rat | mouse | unconjugated | 5 mg | More Info |
| PD-L1 (Atezolizumab biosimilar) | Atezolizumab | Human | human | unconjugated | 100 mg | More Info |
| PD-L1 (Atezolizumab biosimilar) | Atezolizumab | Human | human | unconjugated | 1 mg | More Info |
| PD-L1 (Atezolizumab biosimilar) | Atezolizumab | Human | human | unconjugated | 25 mg | More Info |
| PD-L1 (Atezolizumab biosimilar) | Atezolizumab | Human | human | unconjugated | 50 mg | More Info |
| PD-L1 (Atezolizumab biosimilar) | Atezolizumab | Human | human | unconjugated | 5 mg | More Info |
| PD-L1 (Avelumab biosimilar) | Avelumab | Human | human | unconjugated | 100 mg | More Info |
| PD-L1 (Avelumab biosimilar) | Avelumab | Human | human | unconjugated | 1 mg | More Info |
| PD-L1 (Avelumab biosimilar) | Avelumab | Human | human | unconjugated | 25 mg | More Info |
| PD-L1 (Avelumab biosimilar) | Avelumab | Human | human | unconjugated | 50 mg | More Info |
| PD-L1 (Avelumab biosimilar) | Avelumab | Human | human | unconjugated | 5 mg | More Info |
| PD-L1 (Durvalumab biosimilar) | Durvalumab | Human | human | unconjugated | 100 mg | More Info |
| PD-L1 (Durvalumab biosimilar) | Durvalumab | Human | human | unconjugated | 1 mg | More Info |
| PD-L1 (Durvalumab biosimilar) | Durvalumab | Human | human | unconjugated | 25 mg | More Info |
| PD-L1 (Durvalumab biosimilar) | Durvalumab | Human | human | unconjugated | 50 mg | More Info |
| PD-L1 (Durvalumab biosimilar) | Durvalumab | Human | human | unconjugated | 5 mg | More Info |
| PD-1 (Nivolumab biosimilar) | Nivolumab | Human | human | unconjugated | 100 mg | More Info |
| PD-1 (Nivolumab biosimilar) | Nivolumab | Human | human | unconjugated | 1 mg | More Info |
| PD-1 (Nivolumab biosimilar) | Nivolumab | Human | human | unconjugated | 25 mg | More Info |
| PD-1 (Nivolumab biosimilar) | Nivolumab | Human | human | unconjugated | 50 mg | More Info |
| PD-1 (Nivolumab biosimilar) | Nivolumab | Human | human | unconjugated | 5 mg | More Info |
| PD-1 (Pembrolizumab biosimilar) | Pembrolizumab | Human | human | unconjugated | 100 mg | More Info |
| PD-1 (Pembrolizumab biosimilar) | Pembrolizumab | Human | human | unconjugated | 1 mg | More Info |
| PD-1 (Pembrolizumab biosimilar) | Pembrolizumab | Human | human | unconjugated | 25 mg | More Info |
| PD-1 (Pembrolizumab biosimilar) | Pembrolizumab | Human | human | unconjugated | 50 mg | More Info |
| PD-1 (Pembrolizumab biosimilar) | Pembrolizumab | Human | human | unconjugated | 5 mg | More Info |
| phosphorylated PD-1 | 407.6G12 | Mouse | human, mouse | unconjugated | 100 mg | More Info |
| phosphorylated PD-1 | 407.6G12 | Mouse | human, mouse | unconjugated | 1 mg | More Info |
| phosphorylated PD-1 | 407.6G12 | Mouse | human, mouse | unconjugated | 25 mg | More Info |
| phosphorylated PD-1 | 407.6G12 | Mouse | human, mouse | unconjugated | 50 mg | More Info |
| phosphorylated PD-1 | 407.6G12 | Mouse | human, mouse | unconjugated | 5 mg | More Info |
| Phosphotyrosine | 4G10 | Mouse | n/a | unconjugated | 100 mg | More Info |
| Phosphotyrosine | 4G10 | Mouse | n/a | unconjugated | 1 mg | More Info |
| Phosphotyrosine | 4G10 | Mouse | n/a | unconjugated | 25 mg | More Info |
| Phosphotyrosine | 4G10 | Mouse | n/a | unconjugated | 50 mg | More Info |
| Phosphotyrosine | 4G10 | Mouse | n/a | unconjugated | 5 mg | More Info |
| Podoplanin | 8.1.1 | Syrian Hamster | mouse | unconjugated | 100 mg | More Info |
| Podoplanin | 8.1.1 | Syrian Hamster | mouse | unconjugated | 1 mg | More Info |
| Podoplanin | 8.1.1 | Syrian Hamster | mouse | unconjugated | 25 mg | More Info |
| Podoplanin | 8.1.1 | Syrian Hamster | mouse | unconjugated | 50 mg | More Info |
| Podoplanin | 8.1.1 | Syrian Hamster | mouse | unconjugated | 5 mg | More Info |
| PrP | TW1 | Mouse | human, mouse | unconjugated | 100 mg | More Info |
| PrP | TW1 | Mouse | human, mouse | unconjugated | 1 mg | More Info |
| PrP | TW1 | Mouse | human, mouse | unconjugated | 25 mg | More Info |
| PrP | TW1 | Mouse | human, mouse | unconjugated | 50 mg | More Info |
| PrP | TW1 | Mouse | human, mouse | unconjugated | 5 mg | More Info |
| PSGL-1 | 4RA10 | Rat | mouse | unconjugated | 100 mg | More Info |
| PSGL-1 | 4RA10 | Rat | mouse | unconjugated | 1 mg | More Info |
| PSGL-1 | 4RA10 | Rat | mouse | unconjugated | 25 mg | More Info |
| PSGL-1 | 4RA10 | Rat | mouse | unconjugated | 50 mg | More Info |
| PSGL-1 | 4RA10 | Rat | mouse | unconjugated | 5 mg | More Info |
| RANKL | IK22/5 | Rat | mouse | unconjugated | 100 mg | More Info |
| RANKL | IK22/5 | Rat | mouse | unconjugated | 1 mg | More Info |
| RANKL | IK22/5 | Rat | mouse | unconjugated | 25 mg | More Info |
| RANKL | IK22/5 | Rat | mouse | unconjugated | 50 mg | More Info |
| RANKL | IK22/5 | Rat | mouse | unconjugated | 5 mg | More Info |
| RANKL (Denosumab biosimilar) | Denosumab | Human | human | unconjugated | 100 mg | More Info |
| RANKL (Denosumab biosimilar) | Denosumab | Human | human | unconjugated | 1 mg | More Info |
| RANKL (Denosumab biosimilar) | Denosumab | Human | human | unconjugated | 25 mg | More Info |
| RANKL (Denosumab biosimilar) | Denosumab | Human | human | unconjugated | 50 mg | More Info |
| RANKL (Denosumab biosimilar) | Denosumab | Human | human | unconjugated | 5 mg | More Info |
| Respiratory Syncytial Virus | Palivizumab-CP161 | Recombinant Human | n/a | unconjugated | 100 mg | More Info |
| Respiratory Syncytial Virus | Palivizumab-CP161 | Recombinant Human | n/a | unconjugated | 1 mg | More Info |
| Respiratory Syncytial Virus | Palivizumab-CP161 | Recombinant Human | n/a | unconjugated | 25 mg | More Info |
| Respiratory Syncytial Virus | Palivizumab-CP161 | Recombinant Human | n/a | unconjugated | 50 mg | More Info |
| Respiratory Syncytial Virus | Palivizumab-CP161 | Recombinant Human | n/a | unconjugated | 5 mg | More Info |
| Respiratory Syncytial Virus | Palivizumab-CP169 | Recombinant Human | n/a | unconjugated | 100 mg | More Info |
| Respiratory Syncytial Virus | Palivizumab-CP169 | Recombinant Human | n/a | unconjugated | 1 mg | More Info |
| Respiratory Syncytial Virus | Palivizumab-CP169 | Recombinant Human | n/a | unconjugated | 25 mg | More Info |
| Respiratory Syncytial Virus | Palivizumab-CP169 | Recombinant Human | n/a | unconjugated | 50 mg | More Info |
BIO X CELL
BIO X CELL
39 Labombard Rd.
Lebanon NH 03766
P: 1-866-787-3444
F: 1-603-298-5226
customerservice@bxcell.com
http://www.bxcell.com
Return to Profile